Darya-Varia Laboratoria Tbk PT operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Darya-Varia Laboratoria Tbk PT with three other
pharmaceutical manufacturers in Asia:
Tty Biopharm Company Limited
sales of 3.20 billion Taiwanese Dollars [US$100.62 million]
of which 65%
was Anti-Cancer Drug),
Hyundai Pharmaceutical Company Limited
of South Korea
(109.83 billion Korean Won [US$97.97 million]
of which 85%
was Pharmaceutical), and
Ind-Swift Laboratories Limited
based in India
(6.60 billion Indian Rupees [US$98.34 million]
During the year ended December of 2015, sales at
Darya-Varia Laboratoria Tbk PT were 1.31 trillion Indonesian Rupiahs (US$98.61 million).
increase of 18.3%
versus 2014, when the company's sales were 1.10 trillion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Darya-Varia Laboratoria Tbk PT
(and since 2010, sales have increased a total of 41%).
Sales of Consumer Health saw an increase
that was more than double the company's growth rate: sales were up
40.6% in 2015, from
309.12 billion Indonesian Rupiahs to 434.58 billion Indonesian Rupiahs.
Darya-Varia Laboratoria Tbk PT also saw significant increases in sales in
Toll Manufacturing (up 24.9% to 291.62 billion Indonesian Rupiahs)